Italy's Cancer Pain Management market is projected to grow from $156.48 Mn in 2022 to $227.69 Mn by 2030, registering a CAGR of 4.8% during the forecast period of 2022-2030. The main factors driving the growth would be technological developments in pain management methods and government initiatives. The market is segmented by drug type and by disease. Some of the major players include Molteni Farmaceutici (ITA), Italfarmaco (ITA), Grunenthal Pharma, Pfizer, and Abbott.
Italy's Cancer Pain Management market is projected to grow from $156.48 Mn in 2022 to $227.69 Mn by 2030, registering a CAGR of 4.8% during the forecast period of 2022 - 2030. In 2019, Italy spent $2,906 per person on healthcare or 8.67% of its GDP. In 2019, health spending lagged substantially behind the EU average in both per capita spending and as a percentage of GDP. Approximately 74% of health spending in 2019 was supported by the government, which is less than the 80% average for the EU.
Several illnesses of acute and chronic pain are related to cancer. Gene alterations brought on by cancer affect essential cell-regulatory proteins. These changes encourage abnormal cell behaviour, which then fuels unchecked cell proliferation and the ensuing destruction of neighbouring healthy tissues. By pressing on bones, nerves, and other body parts, these tumours put pressure on the body and cause pain. Cancer pain can also be felt while undergoing severe cancer therapy, particularly in more advanced stages of the disease. In addition to having some of the top pharmaceutical companies actively involved in the development of novel analgesics, Europe is a recognised player in the global market for the treatment of cancer pain.
Market Growth Drivers
The market for cancer pain management in Italy is anticipated to expand as a result of technological developments in pain management methods and goods, such as the creation of new, more potent painkillers and the rise in the use of minimally invasive procedures. Moreover, The Italian government has worked to increase cancer patients' access to pain-management therapies. For instance, the National Cancer Plan has provisions to better manage pain associated with cancer, such as boosting access to specialised pain clinics and the availability of painkillers.
Market Restraints
Despite growing recognition of the need for adequate pain management for cancer patients, Italian patients still lack understanding and education, which may restrict access to efficient pain management treatments. Further, strict regulatory regulations tend to postpone the approval and introduction of novel pain management medicines and limit the accessibility of some goods to patients apply to the Italian market for cancer pain management treatments and limit the market growth.
Key Players
The European Medicines Agency (EMA) and the Italian Ministry of Health oversee the regulatory framework for the market for cancer pain management in Italy. The National Health Service (NHS) in Italy is in charge of administering medical care and paying for prescription drugs. Prior to being marketed in Italy, all pain management medications, including those used to treat cancer pain, must have clearance from the Italian Medicines Agency (AIFA). The approval procedure entails a detailed assessment of the drug's efficacy and safety as well as proof of its affordability.
The National Health Service (NHS) controls the majority of the reimbursement conditions for the Italian cancer pain management market. In Italy, the NHS is in charge of covering all necessary medications, including those used to treat cancer pain. Drug producers and the NHS negotiate prices to determine reimbursement for cancer pain medications, with the final price dependent on the drug's therapeutic value. Drugs with a high perceived therapeutic benefit and a favourable cost-effectiveness ratio are more likely to be reimbursed with favourable terms.
1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By Drug Type (Revenue, USD Billion):
Non-steroidal anti-inflammatory medicines relieve pain at the site of injury by blocking the cyclooxygenase enzyme, which prevents prostaglandin formation. NSAIDs are a class of medications that includes medications with analgesic, antipyretic, and, at higher doses, anti-inflammatory properties.
By Disease Indication (Revenue, USD Billion):
Based on disease Indication the market is segmented into:
Insights10 will provide you with the reports within 10 key parameters which are:
Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.
Stage I: Market Data Collection
Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.
Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.
Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:
Stage II: Market Data Analysis and Statistical Model
Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.
Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.
The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.
The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.
Data Triangulation & Validation:
Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.
We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.
Stage III: Interpretation and Presentation
Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)
Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.
Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
This report addresses
Need more?